Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 5 375-383, Copyright © 1996 by American Association for Cancer Research

ARTICLES

The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics

A Schatzkin, E Lanza, LS Freedman, J Tangrea, MR Cooper, JR Marshall, PA Murphy, JV Selby, M Shike, RR Schade, RW Burt, JW Kikendall and J Cahill
National Cancer Institute, Bethesda, Maryland, USA.

The Polyp Prevention Trial (PPT) is a multicenter randomized controlled trial examining the effect of a low-fat (20% of total energy intake), high-fiber (18 g/1000 kcal), high-vegetable and -fruit (5-8 daily servings) dietary pattern on the recurrence of adenomatous polyps of the large bowel, precursors of most colorectal malignancies. Eligibility criteria include one or more adenomas removed within 6 months of randomization; complete nonsurgical polyp removal and complete colonic examination to the cecum at the qualifying colonoscopy: age 35 years of more; no history of colorectal cancer, inflammatory bowel disease, or large bowel resection; and satisfactory completion of a food frequency questionnaire and 4-day food record. Of approximately 38,277 potential participants with one or more polyps recently resected, investigators at eight clinical centers randomized 2,079 (5.4%; 1,037 in the intervention and 1,042 in the control arm) between June 1991 and January 1994, making the PPT the largest adenoma recurrence trial ever conducted. Of PPT participants, 35% are women and 10% are minorities. At study entry, participants averaged 61.4 years of age; 14% of them smoked, and 22% used aspirin. At the baseline colonoscopy, 35% of participants had two or more adenomas, and 29% had at least one large (> of = 1 cm) adenoma. Demographic, behavioral, dietary, and clinical characteristics are comparable across the two study arms. Participants have repeat colonoscopies after 1 (T(1)) and 4 (T(4)) years of follow-up. The primary end point is adenoma recurrence; secondary end points include number, size, location, and histology of adenomas. All resected lesions are reviewed centrally by gastrointestinal pathologists. The trial provides 90% power to detect a reduction of 24% in the annual adenoma recurrence rate. The primary analytic period, on which sample size calculations were based is 3 years (T(1) to T(4)), which permits a 1-year lag time for the intervention to work and allows a more definitive clearing of lesions at T(1), given that at least 10-15% of polyps may be missed at baseline. The final (T(4)) colonoscopies are expected to be completed in early 1998.

This article has been cited by other articles:

				G. Bobe, L. B. Sansbury, P. S. Albert, A. J. Cross, L. Kahle, J. Ashby, M. L. Slattery, B. Caan, E. Paskett, F. Iber, et al. Dietary Flavonoids and Colorectal Adenoma Recurrence in the Polyp Prevention Trial Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1344 - 1353. [Abstract] [Full Text] [PDF]

				A. O. Laiyemo, G. Murphy, P. S. Albert, L. B. Sansbury, Z. Wang, A. J. Cross, P. M. Marcus, B. Caan, J. R. Marshall, P. Lance, et al. Postpolypectomy Colonoscopy Surveillance Guidelines: Predictive Accuracy for Advanced Adenoma at 4 Years Ann Intern Med, March 18, 2008; 148(6): 419 - 426. [Abstract] [Full Text] [PDF]

				E. Lanza, B. Yu, G. Murphy, P. S. Albert, B. Caan, J. R. Marshall, P. Lance, E. D. Paskett, J. Weissfeld, M. Slattery, et al. The Polyp Prevention Trial Continued Follow-up Study: No Effect of a Low-Fat, High-Fiber, High-Fruit, and -Vegetable Diet on Adenoma Recurrence Eight Years after Randomization Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1745 - 1752. [Abstract] [Full Text] [PDF]

				L. Madlensky, D. Daftary, T. Burnett, P. Harmon, M. Jenkins, J. Maskiell, S. Nigon, K. Phillips, A. Templeton, P. J. Limburg, et al. Accuracy of Colorectal Polyp Self-Reports: Findings from the Colon Cancer Family Registry Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1898 - 1901. [Abstract] [Full Text] [PDF]

				K. L. Wanke, C. Daston, A. Slonim, P. S. Albert, K. Snyder, A. Schatzkin, and E. Lanza Adherence to the Polyp Prevention Trial Dietary Intervention Is Associated with a Behavioral Pattern of Adherence to Nondietary Trial Requirements and General Health Recommendations J. Nutr., February 1, 2007; 137(2): 391 - 398. [Abstract] [Full Text] [PDF]

				T. S. Hudson, M. R. Forman, M. M. Cantwell, A. Schatzkin, P. S. Albert, and E. Lanza Dietary Fiber Intake: Assessing the Degree of Agreement between Food Frequency Questionnaires and 4-Day Food Records. J. Am. Coll. Nutr., October 1, 2006; 25(5): 370 - 381. [Abstract] [Full Text] [PDF]

				E. Lanza, T. J. Hartman, P. S. Albert, R. Shields, M. Slattery, B. Caan, E. Paskett, F. Iber, J. W. Kikendall, P. Lance, et al. High Dry Bean Intake and Reduced Risk of Advanced Colorectal Adenoma Recurrence among Participants in the Polyp Prevention Trial J. Nutr., July 1, 2006; 136(7): 1896 - 1903. [Abstract] [Full Text] [PDF]

				L. B. Sansbury, A. W. Bergen, K. L. Wanke, B. Yu, N. E. Caporaso, N. Chatterjee, L. Ratnasinghe, A. Schatzkin, T. A. Lehman, A. Kalidindi, et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 494 - 501. [Abstract] [Full Text] [PDF]

				E. T Jacobs, E. Lanza, D. S Alberts, C.-H. Hsu, R. Jiang, A. Schatzkin, P. A Thompson, and M. E. Martinez Fiber, sex, and colorectal adenoma: results of a pooled analysis Am. J. Clinical Nutrition, February 1, 2006; 83(2): 343 - 349. [Abstract] [Full Text] [PDF]

				T. J. Hartman, B. Yu, P. S. Albert, M. L. Slattery, E. Paskett, J. W. Kikendall, F. Iber, B. K. Brewer, A. Schatzkin, E. Lanza, et al. Does Nonsteroidal Anti-inflammatory Drug Use Modify the Effect of a Low-Fat, High-Fiber Diet on Recurrence of Colorectal Adenomas? Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2359 - 2365. [Abstract] [Full Text] [PDF]

				M. M. Cantwell, M. R. Forman, P. S. Albert, K. Snyder, A. Schatzkin, E. Lanza, and and The Polyp Prevention Trial Study Group No Association between Fatty Acid Intake and Adenomatous Polyp Recurrence in the Polyp Prevention Trial Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2059 - 2060. [Full Text] [PDF]

				K. Woodson, D. J. Weisenberger, M. Campan, P. W. Laird, J. Tangrea, L. L. Johnson, A. Schatzkin, and E. Lanza Gene-Specific Methylation and Subsequent Risk of Colorectal Adenomas among Participants of the Polyp Prevention Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1219 - 1223. [Abstract] [Full Text] [PDF]

				T. J. Hartman, P. S. Albert, K. Snyder, M. L. Slattery, B. Caan, E. Paskett, F. Iber, J. W. Kikendall, J. Marshall, M. Shike, et al. The Association of Calcium and Vitamin D with Risk of Colorectal Adenomas J. Nutr., February 1, 2005; 135(2): 252 - 259. [Abstract] [Full Text] [PDF]

				E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, et al. Selenium and Colorectal Adenoma: Results of a Pooled Analysis J Natl Cancer Inst, November 17, 2004; 96(22): 1669 - 1675. [Abstract] [Full Text] [PDF]

				P. Maruvada and S. Srivastava Biomarkers for Cancer Diagnosis: Implications for Nutritional Research J. Nutr., June 1, 2004; 134(6): 1640S - 1645S. [Abstract] [Full Text] [PDF]

				J. A. Eastham, E. Riedel, P. T. Scardino, M. Shike, M. Fleisher, A. Schatzkin, E. Lanza, L. Latkany, and C. B. Begg Variation of Serum Prostate-Specific Antigen Levels: An Evaluation of Year-to-Year Fluctuations JAMA, May 28, 2003; 289(20): 2695 - 2700. [Abstract] [Full Text] [PDF]

				J. R. Marshall Methodologic and Statistical Considerations Regarding Use of Biomarkers of Nutritional Exposure in Epidemiology J. Nutr., March 1, 2003; 133(3): 881S - 887. [Abstract] [Full Text] [PDF]

				M. Shike, L. Latkany, E. Riedel, M. Fleisher, A. Schatzkin, E. Lanza, D. Corle, and C. B. Begg Lack of Effect of a Low-Fat, High-Fruit, -Vegetable, and -Fiber Diet on Serum Prostate-Specific Antigen of Men Without Prostate Cancer: Results From a Randomized Trial J. Clin. Oncol., September 1, 2002; 20(17): 3592 - 3598. [Abstract] [Full Text] [PDF]

				K. Woodson, E. Lanza, J. A. Tangrea, P. S. Albert, M. Slattery, J. Pinsky, B. Caan, E. Paskett, F. Iber, J. W. Kikendall, et al. Hormone Replacement Therapy and Colorectal Adenoma Recurrence Among Women in the Polyp Prevention Trial J Natl Cancer Inst, December 5, 2001; 93(23): 1799 - 1805. [Abstract] [Full Text] [PDF]

				A. Schatzkin, E. Lanza, D. Corle, P. Lance, F. Iber, B. Caan, M. Shike, J. Weissfeld, R. Burt, M. R. Cooper, et al. Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas N. Engl. J. Med., April 20, 2000; 342(16): 1149 - 1155. [Abstract] [Full Text] [PDF]

				A. McTiernan, R. S. Schwartz, J. Potter, and D. Bowen Exercise Clinical Trials in Cancer Prevention Research:A Call to Action Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 201 - 207. [Abstract] [Full Text] [PDF]